Regulator of gene expression responsible for the progression of breast cancer

by Bill Hathaway
Gene regulator critical for breast cancer metastasis to the lung is identified
Credit: Shutterstock

Yale Cancer Center researchers have identified a regulator of gene expression that is responsible for the progression of breast cancer and its metastasis to the lung. The study appears online in Cell Reports.

In women, breast cancer is the most common cancer, and the second leading cause of cancer-related death. When it metastasizes, it does so primarily to the lung, brain, and bone. Only limited treatment options are available, and scientists are working to identify and test new drug targets for the development of effective therapies.

Recent studies suggest that abnormal gene expression contributes significantly to tumor formation and progression. But the regulators of such changes in metastasis are poorly understood.

The Yale researchers analyzed datasets of human breast tumors, as well as those of cancer cells, and found that overexpression of the enzyme RBP2 is critical for to the lung. Loss of RBP2, they also found, suppressed in mouse models.

The authors say their evidence suggests that RBP2 regulates a critical epigenetic switch that sets the stage for . They say the enzyme offers a novel target for development of therapies designed to inhibit and metastasis.

"Metastasis is the major cause of breast cancer-related death," said senior author Qin Yan, assistant professor of pathology at Yale School of Medicine. "Our study provides the first evidence, in genetically engineered mice, that a new class of enzymes could be targeted to suppress tumor metastasis."

add to favorites email to friend print save as pdf

Related Stories

New signaling pathway linked to breast cancer metastasis

Apr 02, 2012

Lymph nodes help to fight off infections by producing immune cells and filtering foreign materials from the body, such as bacteria or cancer cells. Thus, one of the first places that cancer cells are found when they leave ...

Recommended for you

Researcher to cancer: 'Resistance will be futile'

4 hours ago

Turning the tables, Katherine Borden at the University of Montreal's Institute for Research in Immunology and Cancer (IRIC) has evoked Star Trek's Borg in her fight against the disease. "Cancer cells rapidly ...

How does prostate cancer form?

6 hours ago

Prostate cancer affects more than 23,000 men this year in the USA however the individual genes that initiate prostate cancer formation are poorly understood. Finding an enzyme that regulates this process ...

Low risk of malignancy for small complex adnexal masses

13 hours ago

(HealthDay)—For older women with small complex adnexal masses, the overall risk of malignancy is low, according to a study published in the December issue of the American Journal of Obstetrics & Gynecology.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.